Filing Details
- Accession Number:
- 0001385508-23-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-31 16:19:24
- Reporting Period:
- 2023-01-27
- Accepted Time:
- 2023-01-31 16:19:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385508 | Opiant Pharmaceuticals Inc. | OPNT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1358116 | Phil Skolnick | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd., Suite 400 Santa Monica CA 90401 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-27 | 480 | $20.26 | 21,548 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
Billionaire Hedge Funds
